Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10183920 Crystal modifications of elobixibat

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Helena Nicklasson0

Martin Bohlin0

Ingvar Ymén0

Thomas Larsson0

Date of Patent

January 22, 2019

0

Patent Application Number

155198080

Date Filed

October 23, 2015

0

Patent Citations Received

US Patent 11377429 Benzothia(di)azepine compounds and their use as bile acid modulators

US Patent 11583539 Treating progressive familial intrahepatic cholestasis (PFIC) with IBAT inhibitors

US Patent 11603359 Benzothiadiazepine compounds and their use as bile acid modulators

0

US Patent 11773071 Benzothiazepine compounds and their use as bile acid modulators

US Patent 11802115 Pharmaceutical formulation of odevixibat

US Patent 11365182 Crystal modifications of odevixibat

Patent Primary Examiner

0

Patent abstract

The present invention relates to crystal modifications of N-{(2R)-2-[({[3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-8-yl]oxy}acetyl)amino]-2-phenylethanolyl}glycine (elobixibat).

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10183920 Crystal modifications of elobixibat

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool